AI model could help improve outcomes of prostate cancer focal therapy

Scientists at UCLA developed an AI model that helps determine how extensive cancer is within the prostate gland

2023-06-27

(Press-News.org) FINDINGS

A new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors determine the extent of cancer within the prostate.

In a series of tests, the AI model was found to be more accurate at predicting tumor margins than magnetic resonance imaging (MRI), potentially improving the effectiveness of focal therapy, standardizing treatment margin definition, and reducing the chance of cancer recurrence.

BACKGROUND

Focal therapy, a minimally invasive treatment approach used for localized tumors, is an alternative treatment for patients with intermediate-risk prostate cancer. The technique involves imaging guidance, such as MRI, to accurately locate the tumor and guide the treatment. Real-time imaging during the procedure helps monitor the treatment progress and ensures the precise delivery of energy to the intended area.

Current methods, however, can underestimate the extent of prostate cancer, complicating the definition of focal treatment margins. AI has the potential to better define these margins than MRI alone, a crucial factor in ensuring accurate diagnosis, precise treatment planning, and effective surgical procedures.

METHOD

Working with scientists at Avenda Health, the team used biopsy data from multiple institutions to train the AI model, called Unfold-AI, to define margins during focal therapy. Testing was then conducted in an independent dataset of 50 patients who had radical prostatectomy for intermediate-risk cancer at the Stanford University School of Medicine. The team found the AI model was more accurate and effective at predicting tumor margins than conventional methods.

IMPACT

The advancement is an outgrowth of research initiated in 2009 by Dr. Leonard Marks, professor and deKernion Endowed Chair in Urology at the David Geffen School of Medicine at UCLA. The software has the potential to help surgeons predict extension into the capsule of the prostate, help radiation therapists boost energy delivery to most important spots, and improve the results of focal ablation of prostate cancer.

Unfold-AI, which is being commercialized by Avenda Health, was spotlighted by NBC News along with President Biden’s AI Summit earlier this month.

JOURNAL

The study was published in the journal European Urology Open Science.

AUTHORS

The study’s first author is Alan Priester, PhD, assistant project scientist in the department of Urology at the David Geffen School of Medicine at UCLA. The study’s senior author is Geoffrey Sonn from the Stanford University School of Medicine. Other UCLA authors include Marks and Shyam Natarajan.

FUNDING

This work was supported in part by the National Cancer Institute (R01CA218547).

COI

Marks and Natarajan are cofounders of Avenda Health. Priester and Shubert are employees of Avenda Health.

END

ELSE PRESS RELEASES FROM THIS DATE:

Revealing the power of citizen science for SDG advancement

2023-06-27

The 17 SDGs are the blueprint to achieve a better and more sustainable future for all. They address the global challenges we face, including climate change, environmental degradation, and inequality. The achievement of the SDGs depends on the ability to accurately measure progress towards meeting the associated targets based on timely, relevant, and reliable data. Citizen science offers an innovative approach to complement and enhance official statistics. Additionally, citizen science can help raise awareness, mobilize action, and therefore achieve transformative change. The collection ...

Bariatric surgery cuts risk for major cardiac events and death in patients with obesity and sleep apnea

2023-06-27

LAS VEGAS – June 27, 2023 – Bariatric surgery, also called weight-loss or metabolic surgery, was associated with a 42% lower risk of major adverse cardiovascular events (MACE), including heart failure, heart attack, stroke, and atrial fibrillation in patients with moderate to severe obstructive sleep apnea (OSA), according to a new study from Cleveland Clinic and presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting. Researchers also report metabolic surgery ...

New study finds fewer heart attacks, strokes and death among patients with diabetes and history of metabolic surgery

2023-06-27

LAS VEGAS – June 27, 2023 – Patients with diabetes and a history of metabolic surgery had significantly fewer heart attacks, strokes, hospitalizations and death compared to matched patients who did not have the surgery, according to a new study* presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting. Patients reduced their chances of winding up in a hospital with a heart attack by more than 35%, a stroke by more than 25% and congestive heart failure by nearly ...

Bariatric surgery guidelines lowered BMI threshold for eligibility, but relatively few heeded the call

2023-06-27

LAS VEGAS – June, 27, 2023 – Patient eligibility for bariatric surgery, also called weight-loss or metabolic surgery, has expanded over the last decade and its safety and effectiveness even further established in clinical studies and professional guidelines, but relatively few patients with a body mass index (BMI) below 35 actually get the surgery in any given year, according to new studies presented here at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting. In one study*, University of Southern California (USC) researchers found only 3.5% of the more than one million bariatric ...

New study finds diabetes remains in remission years after gastric bypass surgery regardless of weight loss

2023-06-27

LAS VEGAS – June 27, 2023 – More than half of patients with diabetes and a history of metabolic surgery (51%) experienced remission of their diabetes even if they did not achieve significant weight loss after surgery, according to a new study* presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting. Researchers from Mayo Clinic in Rochester, University of California San Francisco in Fresno, and Stony Brook University Medical Center in New York performed a multicenter retrospective study of patients with diabetes who underwent gastric ...

More women are using single embryos during fertility treatment

2023-06-27

Copenhagen, Denmark: More women are having just one embryo transferred per cycle of fertility treatment to get pregnant, according to research presented at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. Preliminary data from the ESHRE European IVF-monitoring Consortium (EIM) [2] shows that nearly three in five (57.6%) out of all in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) procedures in 2020 in Europe involved the transfer ...

Algorithm finds sperm in infertile men faster and more accurately than doctors

2023-06-27

Copenhagen, Denmark: A new artificial intelligence (AI) tool can identify sperm in severely infertile men in seconds compared to the hours it takes scientists, according to results presented today (Tuesday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. The study authors say the algorithm they have developed brings hope to men who want a biological child but have no sperm in their semen. Currently, these patients must undergo a procedure where a portion of their testes is removed to help them become fathers. Embryologists extract sperm manually from this biopsy sample to fertilise the partner’s eggs ...

Lupus flare-ups strongly linked to specific bacterial growth in gut

2023-06-27

Recurrent bouts of systemic lupus erythematosus, marked by the body’s immune system attack of its own tissues, closely tracked with measureable upticks in growth in the gut of a certain species of bacteria. New research from NYU Grossman School of Medicine shows that bacterial blooms of the gut bacterium Ruminococcus blautia gnavus occurred at the same time as disease flare-ups in five of 16 women with lupus of diverse racial backgrounds studied over a four-year period. Systemic lupus erythematosus involves damaging inflammation, especially in the kidneys, but also in joints, skin, and blood vessels. ...

This self-driving boat maps underwater terrain

2023-06-27

EL PASO, Texas (June 27, 2023) – Step aside self-driving cars, self-driving boats are here — and they can do more than take you on a cruise. Researchers at The University of Texas at El Paso have constructed a fully autonomous boat that can carry out bathymetric surveys — surveys of the depth and terrain of bodies of water like oceans, rivers and lakes. The team hopes the robotic boat can help simplify the survey process, which usually takes a crew of individuals to complete, as well as assist ...

A new generic treatment for multiple types of cancer

2023-06-27

Researchers led by Katsunori Tanaka at the RIKEN Cluster for Pioneering Research (CPR) in Japan and Hiromitsu Haba at the RIKEN Nishina Center for Accelerator-Based Science (RNC) have developed a new technique that has the potential to generically treat several kinds of cancer, with fewer negative side effects than currently available methods. Published on June 27 in Chemical Science, the proof-of-concept study showed that tumors in mice grew almost three times less and survival was 100% after just one injection of a compound that is designed to emit small amounts of alpha radiation from the inside of cancer cells, thus killing them but sparing ...